论文部分内容阅读
目的:对低分子肝素联合硫酸镁治疗子痫前期的疗效进行观察与探讨。方法:对2013年5月到2015年5月期间在我院接受治疗的40例子痫前期患者进行临床的相关研究,按照随机的原则分为2组,在常规治疗的基础上,对对照组患者进行硫酸镁治疗,对研究组患者进行低分子肝素联合硫酸镁治疗,分析两组患者的临床疗效。结果:研究组患者治疗后的收缩压、舒张压均明显低于对照组患者,24h尿量则明显高于对照组患者(P<0.05),研究组的发生新生儿呼吸窘迫综合症、新生儿窒息、围产儿死亡、胎儿窘迫的情况均明显低于对照组(P<0.05)。结论:对子痫前期患者给予低分子肝素联合硫酸镁治疗的效果较好。
Objective: To observe and discuss the therapeutic effect of low molecular weight heparin and magnesium sulfate on preeclampsia. Methods: From May 2013 to May 2015 in our hospital for treatment of 40 cases of preeclampsia clinical research, according to the principle of random divided into two groups, on the basis of routine treatment, control group patients The patients in the study group were treated with low molecular weight heparin and magnesium sulfate, and the clinical efficacy of the two groups was analyzed. Results: The systolic blood pressure and diastolic blood pressure in study group were significantly lower than those in control group, and the urinary volume in 24h group was significantly higher than that in control group (P <0.05). The study group had neonatal respiratory distress syndrome, neonatal Asphyxia, perinatal death, fetal distress were significantly lower than the control group (P <0.05). Conclusion: The effect of low molecular weight heparin combined with magnesium sulfate on preeclampsia patients is better.